Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH) (SGA)
Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH) by Comparison of Two Regimens of rhGH Administration to SGA Children. Pharmacogenetics of Metabolic Responses to rhGH
Sponsor: Assistance Publique - Hôpitaux de Paris
Terminated
no more inclusions
Other terminated trials from Assistance Publique - Hôpitaux de Paris
- Hepatocellular Carcinoma · Sep 2025
- Memory Consolidation · Phase NA · Aug 2025
- Knee Injuries · Apr 2025
- Metabolic Syndrome · Phase NA · Dec 2024
- Pulmonary Arterial Hypertension · Phase NA · Oct 2024
See all terminations from Assistance Publique - Hôpitaux de Paris
This PHASE4 trial investigates Small for Gestational Age and is currently terminated or withdrawn. Assistance Publique - Hôpitaux de Paris leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Dec 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Dec 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE4
First recorded
Jan 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
- URC-CIC Paris Descartes Necker Cochin
For direct contact, visit the study record on ClinicalTrials.gov .